Plc Gsk serves as Executive at Theravance Biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Plc Gsk has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 16, 2022 involved transacting 9,644,807 shares valued at $94.0M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Sep 16, 2022 | TBPH | $94.0M | Other | 9,644,807 | $9.75 | Discretionary |
Plc Gsk currently holds 0 shares of Theravance Biopharma, Inc. (TBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Plc Gsk has been a net neutral trader of TBPH stock. They have purchased $0 and sold $0 worth of shares.
Plc Gsk's most recent insider trade was on Sep 16, 2022, when they sold 9,644,807 shares at $9.75 per share.
Get notified when new Form 4 filings are submitted